UBX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Unity Biotechnology Inc (UBX).


$16.45M Market Cap.

As of 03/07/2025 5:00 PM ET (MRY) • Disclaimer

UBX Market Cap. (MRY)


UBX Shares Outstanding (MRY)


UBX Assets (MRY)


Total Assets

$37.66M

Total Liabilities

$31.17M

Total Investments

$16.55M

UBX Income (MRY)


Revenue

$0

Net Income

-$25.99M

Operating Expense

$31.17M

UBX Cash Flow (MRY)


CF Operations

-$20.86M

CF Investing

$8.56M

CF Financing

$77.00K

UBX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

UBX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$37,662,000 (-42.67%)

$65,690,000 (-47.17%)

$124,350,000 (-0.29%)

$124,712,000 (-20.22%)

Assets Current

$24,267,000 (-47.93%)

$46,605,000 (-51.72%)

$96,535,000 (6.66%)

$90,504,000 (-10.27%)

Assets Non-Current

$13,395,000 (-29.81%)

$19,085,000 (-31.39%)

$27,815,000 (-18.69%)

$34,208,000 (-38.31%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$6,494,000 (-77.13%)

$28,398,000 (-57.52%)

$66,848,000 (12.22%)

$59,569,000 (-28.13%)

Property Plant & Equipment Net

$12,356,000 (-31.59%)

$18,063,000 (-32.77%)

$26,867,000 (-13.97%)

$31,228,000 (-13.58%)

Cash & Equivalents

$7,580,000 (-61.72%)

$19,803,000 (55.49%)

$12,736,000 (-61.93%)

$33,455,000 (87.88%)

Accumulated Other Comprehensive Income

$15,000 (162.50%)

-$24,000 (90.44%)

-$251,000 (-470.45%)

-$44,000 (-980.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$216,000 (0%)

Total Investments

$16,546,000 (-31.89%)

$24,294,000 (-70.71%)

$82,955,000 (42.88%)

$58,059,000 (-41.48%)

Investments Current

$15,650,000 (-33.11%)

$23,398,000 (-71.49%)

$82,059,000 (48.74%)

$55,170,000 (-30.94%)

Investments Non-Current

$896,000 (0.00%)

$896,000 (0.00%)

$896,000 (-68.99%)

$2,889,000 (-85.04%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$997,000 (-27.75%)

$1,380,000 (-22.91%)

$1,790,000 (-9.82%)

$1,985,000 (-22.40%)

Accumulated Retained Earnings (Deficit)

-$510,343,000 (-5.37%)

-$484,353,000 (-5.31%)

-$459,951,000 (-14.98%)

-$400,024,000 (-17.90%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$19,709,000 (-16.27%)

$23,539,000 (-50.30%)

$47,358,000 (-9.83%)

$52,521,000 (-10.95%)

Debt Current

$0 (0%)

$0 (0%)

$9,476,000 (135.84%)

$4,018,000 (0%)

Debt Non-Current

$19,709,000 (-16.27%)

$23,539,000 (-37.86%)

$37,882,000 (-21.90%)

$48,503,000 (-17.76%)

Total Liabilities

$31,168,000 (-16.42%)

$37,292,000 (-35.15%)

$57,502,000 (-11.73%)

$65,143,000 (-11.30%)

Liabilities Current

$9,260,000 (18.11%)

$7,840,000 (-60.04%)

$19,620,000 (18.07%)

$16,617,000 (14.89%)

Liabilities Non-Current

$21,908,000 (-25.61%)

$29,452,000 (-22.25%)

$37,882,000 (-21.93%)

$48,526,000 (-17.72%)

UBX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$236,000 (-95.07%)

$4,784,000 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$15,460,000 (-18.49%)

$18,966,000 (-9.47%)

$20,949,000 (-9.14%)

$23,056,000 (-4.03%)

Research & Development Expense

$13,006,000 (-35.29%)

$20,099,000 (-45.47%)

$36,859,000 (-4.00%)

$38,393,000 (-42.96%)

Operating Expenses

$31,171,000 (-30.21%)

$44,667,000 (-22.73%)

$57,808,000 (-5.93%)

$61,449,000 (-34.58%)

Interest Expense

$0 (0%)

$2,452,000 (-31.08%)

$3,558,000 (11.99%)

$3,177,000 (145.90%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$25,990,000 (34.80%)

-$39,860,000 (33.49%)

-$59,927,000 (1.31%)

-$60,725,000 (35.29%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$25,990,000 (34.80%)

-$39,860,000 (33.49%)

-$59,927,000 (1.31%)

-$60,725,000 (35.29%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$25,990,000 (34.80%)

-$39,860,000 (33.49%)

-$59,927,000 (1.31%)

-$60,725,000 (35.29%)

Weighted Average Shares

$16,827,038 (13.90%)

$14,773,612 (55.60%)

$9,494,421 (70.10%)

$5,581,587 (9.73%)

Weighted Average Shares Diluted

$16,827,038 (13.90%)

$14,773,612 (55.60%)

$9,494,421 (70.10%)

$5,581,587 (9.73%)

Earning Before Interest & Taxes (EBIT)

-$25,990,000 (30.52%)

-$37,408,000 (33.64%)

-$56,369,000 (2.05%)

-$57,548,000 (37.82%)

Gross Profit

$0 (0%)

$0 (0%)

$236,000 (-95.07%)

$4,784,000 (0%)

Operating Income

-$31,171,000 (30.21%)

-$44,667,000 (22.42%)

-$57,572,000 (-1.60%)

-$56,665,000 (39.67%)

UBX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$8,565,000 (-85.84%)

$60,495,000 (346.47%)

-$24,545,000 (-162.43%)

$39,313,000 (854.86%)

Net Cash Flow from Financing

$77,000 (100.47%)

-$16,340,000 (-129.79%)

$54,855,000 (163.16%)

$20,845,000 (-67.37%)

Net Cash Flow from Operations

-$20,865,000 (43.74%)

-$37,088,000 (27.32%)

-$51,029,000 (-13.25%)

-$45,060,000 (42.48%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$12,223,000 (-272.96%)

$7,067,000 (134.11%)

-$20,719,000 (-237.23%)

$15,098,000 (176.77%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$8,539,000 (-85.86%)

$60,391,000 (343.25%)

-$24,827,000 (-162.84%)

$39,508,000 (966.02%)

Capital Expenditure

$26,000 (-75.00%)

$104,000 (-63.12%)

$282,000 (244.62%)

-$195,000 (69.81%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$21,563,000 (0%)

$0 (0%)

$142,000 (-99.42%)

Issuance (Purchase) of Equity Shares

$77,000 (-98.53%)

$5,223,000 (-90.48%)

$54,855,000 (164.96%)

$20,703,000 (-47.40%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$3,970,000 (-46.49%)

$7,419,000 (-20.90%)

$9,379,000 (-18.82%)

$11,553,000 (-16.36%)

Depreciation Amortization & Accretion

$867,000 (-26.65%)

$1,182,000 (-45.78%)

$2,180,000 (-24.31%)

$2,880,000 (-16.50%)

UBX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

100.00% (0.00%)

100.00%

Profit Margin

-

-

-25392.80% (-1900.54%)

-1269.30%

EBITDA Margin

-

-

-22961.40% (-1909.40%)

-1142.70%

Return on Average Equity (ROAE)

-161.50% (-74.78%)

-92.40% (9.06%)

-101.60% (-10.08%)

-92.30% (2.02%)

Return on Average Assets (ROAA)

-52.70% (-15.82%)

-45.50% (10.61%)

-50.90% (-12.11%)

-45.40% (20.91%)

Return on Sales (ROS)

-

-

-23885.20% (-1885.63%)

-1202.90%

Return on Invested Capital (ROIC)

-48.20% (-15.31%)

-41.80% (3.69%)

-43.40% (-14.21%)

-38.00% (33.22%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.63 (11.33%)

-0.71 (-64.75%)

-0.43 (67.66%)

-1.34 (52.75%)

Price to Sales Ratio (P/S)

-

-

110.23 (547.13%)

17.03

Price to Book Ratio (P/B)

2.53 (154.93%)

0.99 (70.79%)

0.58 (-58.87%)

1.42 (-57.70%)

Debt to Equity Ratio (D/E)

4.8 (265.58%)

1.31 (52.67%)

0.86 (-21.39%)

1.09 (23.48%)

Earnings Per Share (EPS)

-1.54 (42.96%)

-2.7 (57.21%)

-6.31 (42.00%)

-10.88 (41.03%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0.03 (-97.08%)

0.86 (0%)

Free Cash Flow Per Share (FCFPS)

-1.24 (50.54%)

-2.5 (53.17%)

-5.34 (34.08%)

-8.11 (47.78%)

Book Value Per Share (BVPS)

0.39 (-79.92%)

1.92 (-72.70%)

7.04 (-34.02%)

10.67 (-34.50%)

Tangible Assets Book Value Per Share (TABVPS)

2.24 (-49.66%)

4.45 (-66.05%)

13.1 (-41.38%)

22.34 (-27.30%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1 (0.00%)

-1 (50.00%)

-2 (33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.13 (8.98%)

-1.24 (-5.28%)

-1.17 (45.45%)

-2.15 (33.23%)

Asset Turnover

0 (0%)

0 (0%)

0 (-94.44%)

0.04 (0%)

Current Ratio

2.62 (-55.91%)

5.95 (20.83%)

4.92 (-9.66%)

5.45 (-21.91%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$20,839,000 (43.65%)

-$36,984,000 (27.12%)

-$50,747,000 (-12.14%)

-$45,255,000 (42.70%)

Enterprise Value (EV)

$28,252,682 (-36.90%)

$44,772,895 (-29.59%)

$63,590,916 (-45.94%)

$117,632,301 (-59.04%)

Earnings Before Tax (EBT)

-$25,990,000 (34.80%)

-$39,860,000 (33.49%)

-$59,927,000 (1.31%)

-$60,725,000 (35.29%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$25,123,000 (30.65%)

-$36,226,000 (33.15%)

-$54,189,000 (0.88%)

-$54,668,000 (38.65%)

Invested Capital

$40,531,000 (-34.19%)

$61,586,000 (-55.81%)

$139,352,000 (9.59%)

$127,161,000 (-30.52%)

Working Capital

$15,007,000 (-61.29%)

$38,765,000 (-49.60%)

$76,915,000 (4.10%)

$73,887,000 (-14.49%)

Tangible Asset Value

$37,662,000 (-42.67%)

$65,690,000 (-47.17%)

$124,350,000 (-0.29%)

$124,712,000 (-20.22%)

Market Capitalization

$16,452,682 (-41.69%)

$28,217,895 (-27.44%)

$38,886,916 (-53.86%)

$84,277,301 (-69.60%)

Average Equity

$16,095,000 (-62.71%)

$43,159,750 (-26.86%)

$59,008,750 (-10.31%)

$65,794,000 (-33.97%)

Average Assets

$49,294,750 (-43.70%)

$87,555,750 (-25.61%)

$117,701,250 (-11.97%)

$133,712,750 (-18.19%)

Invested Capital Average

$53,941,250 (-39.69%)

$89,446,250 (-31.12%)

$129,866,250 (-14.23%)

$151,418,250 (-6.87%)

Shares

16,850,350 (15.25%)

14,620,671 (3.02%)

14,192,305 (145.86%)

5,772,418 (9.09%)